ILK and colorectal carcinoma: Since PD-L1 expression is involved in suppressing anti-tumor immune cell activity including NK cells (57, 86, 87), we examined whether ILK KD-mediated PD-L1 reduction in the CRC cells will display an effect in immune cell cytotoxicity.